Cantel Medical Corp. (NYSE:CMN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
Cantel Medical Corp. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 19.05% to $0.25 in the quarter versus EPS of $0.21 in the year-earlier quarter.
Revenue: Rose 15.41% to $113.9 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Cantel Medical Corp. reported adjusted EPS income of $0.25 per share. By that measure, the company beat the mean analyst estimate of $0.23. It beat the average revenue estimate of $105.75 million.
Quoting Management: Andrew Krakauer, Cantel’s President and CEO, stated, “We are pleased to have delivered record sales and earnings this quarter. We achieved good financial performance growth in our three major business segments — Endoscopy, Water Purification and Filtration, and Healthcare Disposables. All three business units have greatly benefited from further investments in new product development, sales and marketing programs and the integration of recent acquisitions for this quarter and for the full year. Most importantly this quarter, we had strong organic sales growth of 10% with a total sales increase of over 15%.”
Key Stats (on next page)…